liveBook · Manning

Differential expression analysis

As explained in Build AI Drug Discovery Pipelines

Differential expression analysis identifies genes or transcripts whose expression levels differ systematically between biological conditions or groups.

Differential expression analysis identifies genes with systematically altered expression between biological conditions, such as idiopathic pulmonary fibrosis (IPF) patient tissue and age-matched controls. It helps turn transcriptomic measurements into disease-relevant signals for target discovery. section 13.3.1

Within a target-discovery workflow, the analysis:

  • Finds genes upregulated or otherwise dysregulated in IPF patient lung samples. section 13.3.1
  • Feeds dysregulated genes into pathway enrichment and network analysis to reveal fibrosis-related biology and potential hub genes. section 13.3.1
  • Combines expression evidence with proteomics, genetic associations, and literature-derived relationships when prioritizing targets. section 13.3.1

IPF target discovery

Expression analysis found TNIK upregulated in IPF patient tissue. Combined with genetic and biological evidence, this supported TNIK as a potentially important inflammatory and fibrotic signaling target. section 13.3.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Identifies altered genes and connects them to pathway and network analyses, without detailing statistical implementation.
Examples
Uses IPF patient lung tissue, age-matched controls, and TNIK upregulation as concrete evidence.
What you can do after
Evaluate disease-associated genes for downstream pathway analysis and therapeutic target prioritization.
How it connects
Connects transcriptomics with pathway enrichment, network analysis, GWAS, proteomics, and target identification.

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.